Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue -, Pages 16-22Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2013.04.025
Keywords
Triazole; Antifungal activity; Bioisosteric replacement
Categories
Funding
- National Natural Science Foundation of China [30930107, 81222044]
- Key Project of Science and Technology of Shanghai [10431902100]
- 863 Hi-Tech Program of China [2012AA020302]
- Shanghai Rising-Star Program [12QH1402600]
- Shanghai Municipal Health Bureau [XYQ2011038]
Ask authors/readers for more resources
On the basis of our previously discovered triazole antifungal lead compounds, heterocycle-benzene bioisosteric replacement was used to improve their pharmacokinetic profile. The designed new triazole derivatives have good antifungal activity toward a wide range of pathogenic fungi. Their binding mode with the target enzyme was clarified by molecular docking. The MIC value of the highly potent compound 8f against Candida albicans, Candida tropicalis, and Gyptococcus neoformans is 0.016 mu g/mL, 0.004 mu g/mL, and 0.016 mu g/mL, respectively. Moreover, preliminary pharmacokinetic studies revealed that it showed improved oral absorption as compared to the lead compound iodiconazole and deserved for further evaluations. (C) 2013 Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available